chr7-20379167-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002214.3(ITGB8):c.505G>A(p.Val169Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,611,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002214.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB8 | NM_002214.3 | c.505G>A | p.Val169Ile | missense_variant | 4/14 | ENST00000222573.5 | NP_002205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB8 | ENST00000222573.5 | c.505G>A | p.Val169Ile | missense_variant | 4/14 | 1 | NM_002214.3 | ENSP00000222573 | P1 | |
ITGB8 | ENST00000477859.1 | n.2659G>A | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
ITGB8 | ENST00000478974.1 | n.1210G>A | non_coding_transcript_exon_variant | 4/9 | 1 | |||||
ITGB8 | ENST00000537992.5 | c.100G>A | p.Val34Ile | missense_variant | 5/15 | 2 | ENSP00000441561 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151968Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249402Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134834
GnomAD4 exome AF: 0.0000535 AC: 78AN: 1459068Hom.: 0 Cov.: 30 AF XY: 0.0000551 AC XY: 40AN XY: 725878
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | The c.505G>A (p.V169I) alteration is located in exon 4 (coding exon 4) of the ITGB8 gene. This alteration results from a G to A substitution at nucleotide position 505, causing the valine (V) at amino acid position 169 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at